FDACS Project P0010729 Final Report: September 2017
1
Project Title: Toxicity of Vapor Active Insecticides for Multi-Vector Control 1
2
Principle Investigator: Phillip E. Kaufman, PhD 3
Co-Principle Investigator: Christopher S. Bibbs, PhD Student 4
5
Project Objectives: 6
1. Determine informative concentrations of active ingredient that include metofluthrin, 7
transfluthrin, prallethrin, and flumethrin to determine vapor toxicity against Aedes albopictus, an 8
initial screening species. 9
2. Utilize the informative concentration ranges determined in Objective 1 to replicate the vapor 10
activity bioassays using the four candidate insecticides against three additional vector-capable 11
mosquito species. 12
3. Replicate the vapor activity bioassays and analysis with a fifth candidate insecticide, 13
meperfluthrin, against all prior tested vector-capable mosquito species. 14
15
FDACS Project P0010729 Final Report: September 2017
2
ABSTRACT Objectives 1 and 2 were completed ahead of schedule, so an additional objective 16
was created in adding meperfluthrin to vapor bioassays. Volatile pyrethroid compounds are 17
among the tools commercially dubbed “spatial repellents.” Spatial repellents have been 18
advocated for urban vector management, and there is environmental overlap between mosquitoes 19
found in domestic settings and people that use spatial repellents for outdoor protection. Recent 20
research on several of these spatial repellents indicated considerable adulticidal action. With the 21
idea that these pyrethroid chemicals kill adult mosquitoes, metofluthrin, meperfluthrin, 22
transfluthrin, prallethrin, and flumethrin were evaluated against Aedes albopictus Skuse and 23
Aedes aegypti (L.), Culex pipiens quinquefasciatus Say, and Anopheles quadrimaculatus Say. 24
Dose response LC50 and LC90 data were obtained and analyzed for Ae. albopictus, Ae. aegypti, 25
Cx. quinquefasciatus, and Anopheles quadrimaculatus. It has been determined that transfluthrin 26
vapors had the highest overall toxicity against the four species. Meperfluthrin and metofluthrin 27
vapors demonstrated comparable toxicity. Prallethrin and metofluthrin vapors were similarly 28
toxic against Ae. albopictus, but prallethrin was less toxic than metofluthrin against the other 29
species. Flumethrin was the least toxic against all tested species. 30
31
This project is applicable to the following three Florida Coordinating Council on Mosquito 32
Control research 2016 priorities (rank): 33
1. Pesticide- Efficacy/ Resistance (1) 34
2. Domestic Mosquito Control (3) 35
3. Application- Adulticides (8) 36
37
FDACS Project P0010729 Final Report: September 2017
3
INTRODUCTION 38
Domestic mosquito species, particularly Aedes albopictus Skuse and Aedes aegypti (L.), 39
provoke high levels of nuisance due to their cryptic oviposition that limits mosquito control 40
district treatment options. This is compounded by short flight ranges increasing the localized 41
human contact with these mosquitoes, and low resource demand for these species to reach high 42
numbers, as evidenced by breeding in shallow containers common across domestic properties. 43
These mosquitoes are also the associated vectors for dengue, chikungunya, and Zika viruses 44
(Derraik and Slaney 2015, Ngoagouni et al. 2015, Wilson and Chen 2015). This elevates the risk 45
of emerging pathogen establishment. Domestic risks also extend to Culex pipiens 46
quinquefasciatus Say, which is a ubiquitous urban vector of St. Louis encephalitis virus and 47
West Nile virus, and whose immatures develop in ditches and urban drain infrastructure (Noori 48
et al. 2015). Recently, this species has been suspected to have compatibility with Zika virus in a 49
laboratory study (Ayres 2016). Due to expansive residential development into swampland and 50
estuarine habitat in Florida, Anopheles spp. mosquitoes also are common species of interest in 51
such landscapes, with Anopheles quadrimaculatus Say being the most important U. S. species 52
tied to malaria transmission (Rutledge et al. 2005). Local malaria transmission occasionally 53
occurs, with Palm Beach County, FL being a Florida example (CDC 2003). 54
These examples demonstrate the importance of citizen awareness of risk and the 55
recognition of their employing personal protective solutions to supplement existing mosquito 56
control operations. Mosquito control programs recruit the citizen base as part of this 57
supplementation to be involved in mosquito habitat identification and source reduction (Marciel-58
de-Freitas and Lourenço-de-Oliveira 2011, Dowling et al. 2013, Fonesca et al. 2013). However, 59
the citizen base also can choose to supplement their vector prevention with over-the-counter 60
pesticides. Among those available tools, volatile pyrethroid compounds, or “spatial repellents,” 61
FDACS Project P0010729 Final Report: September 2017
4
have been advocated for urban vector management (Ritchie and Devine 2013). It is important to 62
evaluate the chemicals these consumers use for this supplemental effort. 63
Volatile pyrethroid compounds provide protection in an area well outside the source of 64
chemical dispersion (Achee et al. 2012, Kline and Strickman 2015) and are a marketing 65
alternative to topical repellents that garner favorable usage by citizens (Kline and Strickman 66
2015). By contacting target vectors in a gaseous state, as opposed to the liquid droplets employed 67
by the vast array of mosquito control operations, several different and beneficial properties are 68
achieved in their use. The marketing drive for their use revolves around repellency. Some 69
compounds exhibit repellency, such as metofluthrin repelling Ae. albopictus (Argueta et al. 70
2004), and prallethrin repelling Cx. quinquefasciatus and Culex tritaeniorhynchus Giles (Liu et 71
al. 2009). More consistently, these and similar compounds instigate a confusion or disorientation 72
in vectors including Ae. aegypti (Achee et al. 2009, Ritchie and Devine 2013). Some research 73
studies have reported mosquito mortality following use of these compounds, such as in Ae. 74
aegypti exposure to metofluthrin (Bibbs and Xue 2015, Ritchie and Devine 2013), Ae. albopictus 75
exposure to transfluthrin (Lee 2007), and Anopheles albimanus, Cx. quinquefasciatus, and Ae. 76
albopictus exposure to metofluthrin (Xue et al. 2012). 77
There is a need to measure the toxicity of volatile pyrethroids strictly in the vapor phase 78
to maximize the possibility of these chemicals preventing vector-borne pathogen transmission. 79
Being that volatile pyrethroids already have a pre-existing market in public-use products, a 80
systematic approach comparing the toxicity of candidate vapor active chemicals in a single study 81
may guide future use of these compounds and will provide valuable information to the end user. 82
This project will provide efficacy data on several available volatile pyrethroid compounds 83
against a variety of common domestic vector threats. This would provide an assessment on 84
FDACS Project P0010729 Final Report: September 2017
5
whether these compounds are detrimental or supplemental to the efforts of Florida mosquito 85
control programs, information that will be quite valuable as Florida continues to face the pending 86
arrival of vector-borne threats. 87
MATERIALS AND METHODS 88
Mosquitoes. Mosquito species used in this study were pyrethroid susceptible strains 89
acquired from the United States Department of Agriculture, Agricultural Research Service, 90
Center for Medical, Agricultural, and Veterinary Entomology (USDA-ARS-CMAVE) in 91
Gainesville, Florida. The strains used were the 1952 Orlando, FL, strain Ae. aegypti; 1998 92
Gainesville, FL, strain Ae. albopictus; 1952 Orlando, FL, strain Cx. quinquefasciatus; and 1952 93
Orlando, FL, strain An. quadrimaculatus. Mosquito strains were not exposed to insecticides prior 94
to evaluation and were not supplemented with wild-type introductions to the colonies. Rearing 95
conditions consisted of 26.6 °C, 85 ± 5% relative humidity (RH), with a photoperiod of 14:10 96
(L:D). Batches of 2,000 eggs were placed in larval pans containing 2,500 ml of reverse osmosis 97
(RO) water. Larvae were fed 1-3 g of liver and yeast mixture at a 3:2 ratio ad libitum in a 50-ml 98
suspension. Adult mosquitoes were kept in flight cages containing separate supplies of 10% 99
sucrose solution and reverse osmosis (RO) water. Subjects used in experiments were non-blood-100
fed, 5-7 day-old female mosquitoes. 101
Chemicals. Technical grade prallethrin (32917 Pestanal, Sigma-Aldrich Co. LLC, St. 102
Louis, MO), flumethrin (N-13139, Chem Service, Inc., West Chester, PA), transfluthrin (N-103
13626, Chem Service, Inc., West Chester, PA), meperfluthrin (32065 Pestanal, Sigma-Aldrich 104
Co. LLC, St. Louis, MO), and metofluthrin were selected for this test. Metofluthrin was 105
extracted from OFF! Clip-on over-the-counter refill packs (31.2% metofluthrin, S. C. Johnson & 106
Son, Racine, WI) using pentane. Extracts were fractionated using automated flash 107
FDACS Project P0010729 Final Report: September 2017
6
chromatography (CombiFlash Rd 200i, Teledyne ISCO, Lincoln, NE) (Fig. 1) with simultaneous 108
electrospray ionization mass spectrometry (ESI-MS/MS) (Expressions CMS, Advion, Inc., 109
Ithaca, NY) (Fig. 2). Fractions were delivered using pentane as the non-polar solvent and ethyl 110
ether as the polar solvent at a 10 ml/min flow rate and a 5 ml peak runtime. Solvent was reduced 111
in a rotary evaporator and the resultant technical grade product was checked using gas 112
chromatography mass spectrometry (Supp. Fig. 1, Supp. Fig. 2.1 – 2.2). Each technical grade 113
pyrethroid was serially diluted in acetone to create screening concentrations of 5.00%, 1.00%, 114
0.50%, 0.10%, 0.05%, and 0.01% solutions by weight and stored in amber borosilicate vials (14-115
955-331, Thermo Fisher Scientific, Hampton, NH). Up to seven additional concentrations 116
(different for each chemical) were selected with respect to the initial six range-finding dilutions, 117
for a total of up to 13 concentrations, to collect sufficient data to determine LC50 and LC90 values 118
for each chemical with each mosquito species. 119
Fumigant Bioassays. Test cages consisted of single-use 473 ml clear polypropylene 120
snap-lid cups (MN16-0100, Dart Container Corp, Mason, MI) with the lid modified to have a 121
central 20-mm opening. Twenty female mosquitoes of a single species were aspirated into each 122
container. Filter paper strips (Grade 1 MFR# 28413934, Whatman PLC, Little Chalfont, UK) 123
were cut into 5-mm widths and 40-mm lengths and pleated every 5 mm before being treated with 124
40-µl of a chemical solution (Fig 3). Treated strips were allowed 6-min drying periods before 125
transfer into a mesh bag (Nylon Tulle No: 147356, Falk Industries, Inc., New York, NY) that 126
was suspended within the test cage through the hole in the modified lid (Fig 4). The hole was 127
then sealed to prevent vapor escape during testing. One concentration of a single chemical was 128
used in each treatment cage. Controls were strips treated with only acetone. Test cages were 129
stored in an incubator (Precision Mo: 818, Thermo Fisher Scientific, Hampton, NH) to maintain 130
FDACS Project P0010729 Final Report: September 2017
7
26.6 °C, 85 ± 5% RH, with a photoperiod of 14:10 (L:D) for the duration of data collection. 131
Mesh bags holding the filter paper strip were removed from cages after 2 hours and replaced 132
with a cotton ball soaked with a 10% sucrose solution. Contamination was limited through a 133
strict requirement that no cage materials were reused in subsequent tests. 134
Residual activity data were collected by allowing mosquitoes exposed to vapors to 135
remain in the original testing containers for the 24-hr test duration. Mosquitoes in a prone 136
position and suffering from ataxia that prevented proper upright resting, walking, and flight were 137
considered moribund. Mosquitoes in a prone position and rigidly immobilized were considered 138
dead. The mortality scored in a test cage was comprised of the total combined score of moribund 139
and dead mosquitoes. Mortality was scored at 2, 4, and 24 hours post exposure. 140
A second series of experiments following the above test cage construction and exposure 141
procedures was performed to assess recovery from vapor exposure. The holding conditions 142
deviate in that mosquitoes were transferred to untreated test cages after exposing them to vapors 143
for 2 hours. Mortality was scored by the same procedures. Mortality was recorded for these 144
insects only after being held for 24 hours. This was repeated for all mosquito species and 145
chemical concentrations to assess potential for metabolic recovery after treatment. 146
Data analysis. Probit analyses were performed in PoloPlus (Version 1.0, LeOra Software 147
LLC, Cape Girardeau, MO) to determine descriptive statistics and predictive dose responses of 148
prallethrin, flumethrin, transfluthrin, metofluthrin, and meperfluthrin for Ae. aegypti, Ae. 149
albopictus, Cx. quinquefasciatus, and An. quadrimaculatus at each repeated measure of time. A 150
minimum of four replications with at least 2,080 individuals for each mosquito species were used 151
per chemical to generate LC50 and LC90 values with a 95% confidence limits (CL), expressed in 152
m/v (mass/volume or g/100 ml). Data was discarded if control mortality in excess of 10% 153
FDACS Project P0010729 Final Report: September 2017
8
occurred within a replicate. Probit analysis included correction for control mortality using 154
Abbott’s formula (Abbott 1925). If the lower CL and upper CL of two LC values did not 155
overlap, either within one chemical but across species or with any chemical but within species, 156
then the difference was considered significant (p < 0.05). Variation between chemicals and 157
across time points was analyzed in JMP 13.1.0 (SAS Institute, Inc., Cary, NC) using repeated 158
measures ANOVA. 159
RESULTS 160
As identified in our grant objectives, we completed testing of Ae. albopictus, Ae. aegypti, 161
Cx. quinquefasciatus, and An. quadrimaculatus with all four original candidate chemicals as well 162
as one additional chemical, meperfluthrin. Objective 1 and 2 has been completed. The LC50 and 163
LC90 values representing vapor toxicity of each pyrethroid against Ae. albopictus, Ae. aegypti, 164
Cx. quinquefasciatus, and An. quadrimaculatus are listed in Table 1 and Table 2, respectively. 165
Toxicity responses for many of the selected chemistries were mixed when evaluated 166
across the tested mosquito species. Confidence limit comparisons with LC50 values indicated 167
meperfluthrin had the highest vapor toxicity against Ae. albopictus, Ae. aegypti, and An. 168
quadrimaculatus. Transfluthrin had the second highest toxicity, followed by metofluthrin, 169
prallethrin, and then flumethrin. In contrast, transfluthrin demonstrated the highest toxicity in Cx. 170
quinquefasciatus, followed by meperfluthrin, prallethrin, metofluthrin, and flumethrin. 171
Flumethrin vapors were much less toxic than the differences observed between any other 172
comparisons of tested pyrethroids, regardless of species. When taken with LC90 comparisons, 173
transfluthrin and meperfluthrin were not significantly different in responses generated against Ae. 174
albopictus, Cx. quinquefaciatus, and An. quadrimaculatus. When evaluating the confidence 175
FDACS Project P0010729 Final Report: September 2017
9
limits at LC90 of sets where mosquitoes were exposed for 2-hr then transferred for metabolic 176
recovery, transfluthrin was more toxic than meperfluthrin against all four species. 177
Repeated measures ANOVA indicated a statistically significant increase in mortality 178
between 2-hr, 4-hr, and 24-hr time points within each chemical against Ae. albopictus (F = 0.97, 179
df = 2, p < 0.0001), Ae. aegypti (F = 0.95, df = 2, p < 0.0001), Cx. quinquefasciatus (F = 175.80, 180
df = 2, p < 0.0001) and An. quadrimaculatus (F = 163.84, df = 2, p < 0.0001). Differences in the 181
relative toxicity between chemicals was observed as exposure time increased against Ae. 182
albopictus (F = 15.86, df = 4, p < 0.0001), Ae. aegypti (F = 9.10, df = 4, p < 0.0001), Cx. 183
quinquefasciatus (F = 7.72, df = 4, p < 0.0001) and An. quadrimaculatus (F = 29.41, df = 4, p < 184
0.0001), with the slopes being different between chemicals. 185
DISCUSSION 186
Mosquitoes. Susceptible mosquito strains were acquired through Joyce Urban, the 187
USDA-ARS-CMAVE collaborator included in the submission of the grant. Joyce Urban, Haze 188
Brown, and Greg Knue assisted in the training of an insectary technician for the grant and 189
delivered a starting egg clutch to begin the experiment colonies. As with Ae. albopictus, 190
pyrethroid susceptible strain colonies of Aedes aegypti, Culex quinquefasciatus, and An. 191
quadrimaculatus were established from eggs provided by the USDA-ARS-CMAVE. These 192
colonies were maintained in the same abiotic conditions as Ae. albopictus, but in different rooms 193
of the rearing facility. 194
Chemicals. Metofluthrin was difficult to acquire. Through a different collaborative 195
agreement offered at the time of the grant’s submission, Dr. Uli Bernier and associates with the 196
USDA-ARS-CMAVE team assisted with extraction of metofluthrin from commercially-available 197
FDACS Project P0010729 Final Report: September 2017
10
products in order to circumvent supply barriers (Fig. 1, Fig. 2, Supp. Fig. 1, Supp. Fig. 2.1 – 2.2). 198
The metofluthrin extracted was sufficient to test in the four intended mosquito species. 199
Fumigant Bioassays. The original testing design was inefficient with vapor dispersal. A 200
borosilicate glass housing was used to exclude mosquitoes from physical contact during testing 201
(Fig 4). This design resulted in limited and inconsistent mortality data, perhaps due to vapors 202
being unable to disperse upwards and out of the vial in a consistent manner. Preliminary data 203
generated by the old design were set aside. A new data set was collected using the modified 204
design reported in the Materials and Methods section. We have generated LC50 and LC90 data, 205
with results tabulated in this report (Table 1, Table 2). With the data acquired from the adapted 206
experimental design the LC50 and LC90 values for these three species were successfully 207
completed along with the addition of meperfluthrin (Table 1, Table 2). Objectives 1 and 2 are 208
considered completed. 209
Upon conclusion of study, some residual contamination and degradation of resources was 210
accounted for among rearing supplies, bioassay tools and materials, and technical grade chemical 211
stores. Replacement of contaminated, damaged, or otherwise compromised resources utilized 212
within the duration of this study was exacted from the leftover supply funding in the grant. The 213
allocation of funding and supplies was sufficient to address the expected needs. 214
Importance to Florida Mosquito Control. Transfluthrin, meperfluthrin, and 215
metofluthrin are type-I pyrethroids containing polyfluorinated alcohols in their structure. These 216
chemistries generated higher mortality than either prallethrin, a non-fluorinated type-pyrethroid 217
already used as a mosquito control adulticide, and flumethrin, a type-II pyrethroid with a 218
monofluorinated alcohol. Volatile pyrethroids containing polyfluorinated alcohols appear to be 219
better development targets based on the results of this dose response study. Very poor 220
FDACS Project P0010729 Final Report: September 2017
11
performance was observed with flumethrin across all species, with the lowest activity observed 221
in Ae. albopictus. It is suspected that limited vaporization pressure with flumethrin is the cause 222
of the reduced efficacy. After reviewing literature again and discussing actions with 223
collaborating toxicologists, appropriate formulation could circumvent this drawback. We are 224
investigating possible avenues to improve the delivery of flumethrin with future work. 225
Because of the consistently low activity of flumethrin, meperfluthrin was added to the 226
treatment assays. Meperfluthrin generally performed as well or better than transfluthrin when 227
comparing LC50 values. However, when comparing LC90 values and the sets in which mosquitoes 228
were transferred to clean containment for recovery, transfluthrin and meperfluthrin generally 229
performed equivalently, with transfluthrin outperforming meperfluthrin against Ae. albopictus, 230
Ae. aegypti, and Cx. quinquefasciatus. Interestingly, treatments in which mosquitoes were 231
transferred to clean containment after exposure to enable metabolic recovery resulted in 232
transfluthrin yielding the highest toxicity against all four mosquito species. The LC50 is generally 233
a metric with fewer errors when comparing chemistries, and by this metric meperfluthrin was the 234
highest performing compound against all species. However, the LC90 is more relevant to future 235
interest because of the need to attain a minimum of 80% effect for target chemistries to move 236
forward in product development. The cohorts in which mosquitoes were allowed to recover from 237
exposure in clean containment are also more realistic to application environments, because it is 238
unlikely that mosquitoes will have sustained contact for long periods of time. By the LC90 239
metrics, particularly when evaluating the recovery group, transfluthrin significantly 240
outperformed meperfluthrin. This suggests that transfluthrin is a more pragmatic chemistry to 241
examine in future study. 242
FDACS Project P0010729 Final Report: September 2017
12
To date, transfluthrin and meperfluthrin are not components in any EPA labeled products 243
in the United States. These two chemistries could be good candidates to move forward with 244
product development given the success of metofluthrin, an active ingredient in several EPA 245
registered products. Furthermore, the potency of all three of these pyrethroids with 246
polyfluorinated alcohols warrants study in other areas. Spatial repellents are only one delivery 247
mechanism for these chemistries, and it is still unclear what sub-lethal impacts might occur in 248
vectors when the targets are exposed to pyrethroid vapors. How vapor active compounds, 249
especially volatile pyrethroids, interface with resistance management issues is also an 250
unanswered dilemma. However, there are benefits to working with vapors. 251
Traditional adulticiding, in which pyrethroids are a critical chemical class for public 252
health pest control, relies on dispersing find droplets through the air to deliver active ingredients 253
to the mosquito. The chemistry must impinge upon and penetrate into the cuticle of the target. A 254
weak, but common and non-selective, resistance mechanism is to have resistance to penetration. 255
Volatile pyrethroids are vapors. This promotes a different route of entry that potentially bypasses 256
penetration resistance due to inhaling the toxin instead of absorbing it through the outer cuticle. 257
Furthermore, the higher performing chemistries evaluated in this study, pyrethroids with 258
polyfluorinated alcohols, are intended to be resilient to detoxification enzymes due to the 259
fluorine molecules occluding target sites for cytochrome p450. Metabolic resistance is a strong 260
mechanism for reducing the efficacy of public health treatment efforts. In addition, resistance 261
mechanisms tend to have multiplicative interaction with each other. Therefore, compounds with 262
qualities that mitigate more than one pathway of resistance are practical topics of study. We 263
believe transfluthrin, meperfluthrin, and metofluthrin are strong candidates as vapor active 264
insecticides. 265
FDACS Project P0010729 Final Report: September 2017
13
ACKNOWLEDGEMENTS 266
Funding was provided by the Florida Department of Agriculture and Consumer Services 267
project P0010729. Gratitude is extended to Maia Tsikolia, Nurhayat Tabanca, and Ulrich Bernier 268
from the USDA-ARS-CMAVE for sharing lab space, equipment, and their expertise in the 269
chemical extraction of metofluthrin. Jeff Bloomquist’s logistical consultation is appreciated for 270
facilitating completion of the work to date. 271
REFERENCES CITED 272
Abbott, W. S. 1925. A method of computing the effectiveness of an insecticide. J Econ 273
Entomol, 18: 265-267. 274
Achee, N.L., M.J. Bangs, R. Farlow, G.F. Killeen, S. Lindsay, J.G. Logan, S.J. Moore, M. 275
Rowland, K. Sweeney, S.J. Torr, and J.P. Grieco. 2012. Spatial repellents: from 276
discovery and development to evidence-based validation. Malaria J. 11: 164. DOI: 277
10.1186/1475-2875-11-164. 278
Achee, N.L., M.R. Sardelis, I. Dusfour, K.R. Chauhan, and J.P. Grieco. 2009. 279
Characterization of spatial repellent, contact irritant, and toxicant chemical actions of 280
standard vector control compounds. J. Am. Mosq. Control Assoc. 25: 156-167. 281
Argueta, T.B.O., H. Kawada, and M. Takagi. 2004. Spatial repellency of metofluthrin-282
impregnated multilayer paper against Aedes albopictus under outdoor conditions, 283
Nagasaki, Japan. Med. Entomol. Zool. 55: 211-216. 284
Ayres, C. 2016. Research indicates another common mosquito may be able to carry Zika. In 285
Prada, P., B. Hirschler, W. Dunham (eds.), Reuters: Life, science web news. 286
http://www.reuters.com/article/us-health-zika-brazil-idUSKCN0W52AW (Last accessed 287
12 January 2017) 288
FDACS Project P0010729 Final Report: September 2017
14
Bibbs, C.S. and R.D. Xue. 2015. OFF! Clip-on repellant device with metofluthrin tested on 289
Aedes aegypti (Diptera: Culicidae) for mortality at different time intervals and distances. 290
J. Med. Entomol. DOI: 10.1093/jme/tjv200 291
Bibbs, C.S., A.P. Fulcher, and R.D. Xue. 2015. Allethrin based mosquito control device 292
causing knockdown, morbidity, and mortality in four species of field-caught mosquitoes 293
(Diptera: Culicidae). J. Med. Entomol. 52: 739-742. 294
CDC. 2003. Local Transmission of Plasmodium vivax Malaria --- Palm Beach County, Florida, 295
2003 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5238a3.htm (Last accessed 15 296
April 2016). 297
Derraik, J.G. and D. Slaney. 2015. Notes on Zika virus—an emerging pathogen in the South 298
Pacific. Aust. N.Z. J. Publ. Heal. 39: 5-7. 299
Dowling, Z., P. Armbruster, S.L. LaDeau, M. DeCotiis, J. Mottley, and P.T. Leisnham. 300
2013. Linking mosquito infestation to resident socioeconomic status, knowledge, and 301
source reduction practices in sub-urban Washington, DC. Ecohealth, 10: 36-47. 302
Fonesca, D.M., I. Unlu, T. Crepeau, A. Farajollahi, S.P. Healy, K. Bartlett-Healy, D. 303
Strickman, R. Guagler, G. Hamilton, D. Kline, and G.G. Clark. 2013. Area-wide 304
management of Aedes albopictus. Part 2: Gauging the efficacy of traditional integrated 305
pest control measures against urban container mosquitoes. Pest Manag. Sci., 69: 1351-306
1361. 307
Kaufman, P.E., R.S. Mann, and J.F. Butler. 2011. Insecticidal potency of novel compounds 308
on multiple insect species of medical and veterinary importance. Pest Manag. Sci. 67: 309
26-35. 310
FDACS Project P0010729 Final Report: September 2017
15
Kline, D.L. and D. Strickman. 2015. Spatial or Area Repellents, pp .239-251. In Debboun, M., 311
S. P. Frances, and D.A. Strickman (eds.), Insect Repellents Handbook, 2nd Edition. CRC 312
Press, Boca Raton, FL. 313
Lee, D.K. 2007. Lethal and repellent effects of transfluthrin and metofluthrin used in portable 314
blowers for personal protection against Ochlerotatus togoi and Aedes albopictus (Diptera: 315
Culicidae). Entomol. Res., 37: 173-179. 316
Liu, W.H., S.W. Cai, J. Wu, L.F. Lin, J.H. Duan, and Q. Zou. 2009. Research on the efficacy 317
of four kinds of electric liquid repellents for the Japanese encephalitis vectors in the field. 318
Chinese J. Vector Bio. Control, 20: 505-506. 319
Marciel-de-Freitas, R. and R. Lourenço-de-Oliveira. 2011. Does targeting key-containers 320
effectively reduce Aedes aegypti population density? Trop. Med. Int. Health, 16: 965-321
973. 322
Ngaogouni, C., B. Kamgang, E. Nakoune, C. Paupy, and M. Kazanji. 2015. Invasion of 323
Aedes albopictus (Diptera: Culicidae) into central Africa: what consequences for 324
emerging diseases? Parasit. Vectors 8: 191. 325
Noori, N., B.G. Lockaby, and L. Kalin. 2015. Larval development of Culex quinquefasciatus in 326
water with low to moderate pollution levels. J. Vector Ecol., 40: 208-220. 327
Ritchie, S. A. and G. J. Devine. 2013, Confusion, knock-down and kill of Aedes aegypti using 328
metofluthrin in domestic settings: a powerful tool to prevent dengue transmission? 329
Parasit. Vectors. 6: 262. 330
Rutledge, R.C., R.H. Baker, C.D. Morris, and J.K. Nayar. 2005. Human malaria. University 331
of Florida, EDIS, MG103. http://edis.ifas.ufl.edu/MG103 (Last accessed 15 April 2016). 332
FDACS Project P0010729 Final Report: September 2017
16
Wilson, M.E. and L.H. Chen. 2015. Dengue: Update in Epidemiology. Curr. Infect. Dis. Rep. 333
17: 457. 334
Xue, R. D., W. A. Qualls, J. Phillips, and T. Y. Zhao. 2012. Insecticidal activity of five 335
commercial mosquito coils against Anopheles albimanus, Aedes albopictus, and Culex 336
quinquefasciatus. J Am Mosq Control Assoc, 28: 131-133. 337
FDACS Project P0010729 Final Report: September 2017
17
Tables 338
339
340
Table 1. Comparative LC50 of four volatile pyrethroids, delivered as a vapor, to susceptible strains of four vector mosquito species a Exposure Reading b Pyrethroid Ae. albopictus Ae. aegypti
2 hours Transfluthrin 0.052 (0.038 – 0.072) 0.055 (0.039 – 0.078) Meperfluthrin 0.035 (0.025 – 0.051) 0.025 (0.018 – 0.034) Metofluthrin 0.588 (0.427 – 0.809) 0.269 (0.183 – 0.396) Prallethrin 0.936 (0.660 – 1.327) 0.673 (0.471 – 0.963) Flumethrin 16.222 (10.083 – 26.100) 8.956 (3.143 – 25.519) 4 hours Transfluthrin 0.034 (0.025 – 0.047) 0.034 (0.023 – 0.050) Meperfluthrin 0.026 (0.018 – 0.038) 0.019 (0.014 – 0.028) Metofluthrin 0.444 (0.351 – 0.561) 0.159 (0.105 – 0.241) Prallethrin 0.335 (0.210 – 0.533) 0.445 (0.302 – 0.654) Flumethrin 11.390 (7.604 – 17.060) 2.215 (0.906 – 5.419) 24 hours Transfluthrin 0.029 (0.023 – 0.037) 0.002 (0.001 – 0.006) Meperfluthrin 0.019 (0.013 – 0.028) 0.015 (0.011 – 0.022) Metofluthrin 0.318 (0.246 – 0.410) 0.053 (0.035 – 0.080) Prallethrin 0.222 (0.137 – 0.359) 0.280 (0.187 – 0.419) Flumethrin 7.662 (5.464 – 10.744) 1.842 (0.769 – 4.409) 2 hours, Transfluthrin 0.041 (0.031 – 0.054) 0.043 (0.036 – 0.053) transferred Meperfluthrin 0.048 (0.034 – 0.067) 0.030 (0.022 – 0.043) Metofluthrin 0.848 (0.661 – 1.088) 0.077 (0.050 – 0.120) Prallethrin 0.543 (0.417 – 0.706) 1.139 (0.599 – 2.167) Flumethrin 11.508 (7.600 – 17.426) 11.114 (3.484 – 35.455) a Values are LC50 with 95% fiduciary limits (lower FL, upper FL) shown in ppm (µg/cm3 or µg/ml). Based on serial dilutions of compounds applied to paper strips in a 473.18 ml air space. b Mosquitoes exposed without removal from original test container (2 hr, 4 hr, and 24 hr) and mortality recorded or exposed for 2 hr and transferred to clean containers with mortality recorded 24 hr after initial exposure.
FDACS Project P0010729 Final Report: September 2017
18
Table 1, Continued. Comparative LC50 of four volatile pyrethroids, delivered as a vapor, to susceptible strains of four vector mosquito species a Exposure Reading b Pyrethroid Cx. quinquefasciatus An. quadrimaculatus
2 hours Transfluthrin 0.017 (0.011 – 0.026) 0.023 (0.016 – 0.032) Meperfluthrin 0.024 (0.016 – 0.036) 0.015 (0.010 – 0.024) Metofluthrin 0.384 (0.256 – 0.576) 0.040 (0.030 – 0.055) Prallethrin 0.211 (0.137 – 0.326) 0.369 (0.255 – 0.533) Flumethrin 3.382 (1.626 – 7.037) 69.153 (29.375 – 162.797) 4 hours Transfluthrin 0.011 (0.008 – 0.017) 0.016 (0.011 – 0.022) Meperfluthrin 0.021 (0.014 – 0.031) 0.012 (0.007 – 0.018) Metofluthrin 0.227 (0.151 – 0.341) 0.032 (0.023 – 0.045) Prallethrin 0.150 (0.100 – 0.225) 0.290 (0.199 – 0.422) Flumethrin 2.631 (1.247 – 5.552) 44.988 (18.870 – 107.258) 24 hours Transfluthrin 0.008 (0.005 – 0.014) 0.011 (0.007 – 0.015) Meperfluthrin 0.011 (0.007 – 0.018) 0.009 (0.006 – 0.014) Metofluthrin 0.142 (0.092 – 0.219) 0.023 (0.017 – 0.030) Prallethrin 0.091 (0.057 – 0.145) 0.202 (0.134 – 0.305) Flumethrin 2.135 (0.996 – 4.573) 22.282 (9.987 – 49.715) 2 hours, Transfluthrin 0.020 (0.014 – 0.028) 0.043 (0.032 – 0.058) transferred Meperfluthrin 0.036 (0.025 – 0.050) 0.020 (0.013 – 0.030) Metofluthrin 0.729 (0.510 – 1.041) 0.033 (0.025 – 0.043) Prallethrin 0.277 (0.201 – 0.382) 0.463 (0.315 – 0.680) Flumethrin 5.421 (2.567 – 11.448) 56.002 (22.710 – 138.102) a Values are LC50 with 95% fiduciary limits (lower FL, upper FL) shown in ppm (µg/cm3 or µg/ml). Based on serial dilutions of compounds applied to paper strips in a 473.18 ml air space. b Mosquitoes exposed without removal from original test container (2 hr, 4 hr, and 24 hr) and mortality recorded or exposed for 2 hr and transferred to clean containers with mortality recorded 24 hr after initial exposure.
341
FDACS Project P0010729 Final Report: September 2017
19
342
343
Table 2. Comparative LC90 of four volatile pyrethroids, delivered as a vapor, to susceptible strains of four vector mosquito species a Exposure Reading b Pyrethroid Ae. albopictus Ae. aegypti
2 hours Transfluthrin 0.229 (0.167 – 0.315) 0.350 (0.247 – 0.496) Meperfluthrin 0.238 (0.166 – 0.342) 0.133 (0.095 – 0.184) Metofluthrin 2.342 (1.702 – 3.224) 2.570 (1.750 – 3.775) Prallethrin 4.424 (3.121 – 6.272) 4.149 (2.900 – 5.936) Flumethrin 135.870 (84.450 – 218.600) 2727.086 (957.076 – 7770.547) 4 hours Transfluthrin 0.153 (0.112 – 0.209) 0.278 (0.187 – 0.412) Meperfluthrin 0.202 (0.138 – 0.295) 0.125 (0.087 – 0.179) Metofluthrin 1.518 (1.202 – 1.918) 1.424 (0.940 – 2.160) Prallethrin 3.388 (2.129 – 5.393) 3.362 (2.286 – 4.944) Flumethrin 72.330 (48.290 – 108.339) 294.724 (120.486 – 720.935) 24 hours Transfluthrin 0.076 (0.059 – 0.097) 0.058 (0.024 – 0.141) Meperfluthrin 0.132 (0.092 – 0.191) 0.101 (0.069 – 0.146) Metofluthrin 1.298 (1.005 – 1.677) 0.487 (0.323 – 0.733) Prallethrin 2.162 (1.337 – 3.495) 1.810 (1.210 – 2.706) Flumethrin 36.296 (25.884 – 50.895) 205.738 (85.927 – 492.609) 2 hours, Transfluthrin 0.160 (0.121 – 0.210) 0.108 (0.089 – 0.132) transferred Meperfluthrin 0.277 (0.197 – 0.392) 0.175 (0.125 – 0.245) Metofluthrin 2.899 (2.260 – 3.719) 0.847 (0.546 – 1.314) Prallethrin 1.675 (1.286 – 2.180) 33.801 (17.766 – 64.308) Flumethrin 73.544 (48.567 – 111.366) 5527.478 (1732.754 – 17632.628) a Values are LC50 with 95% fiduciary limits (lower FL, upper FL) shown in ppm (µg/cm3 or µg/ml). Based on serial dilutions of compounds applied to paper strips in a 473.18 ml air space. b Mosquitoes exposed without removal from original test container (2 hr, 4 hr, and 24 hr) and mortality recorded or exposed for 2 hr and transferred to clean containers with mortality recorded 24 hr after initial exposure.
FDACS Project P0010729 Final Report: September 2017
20
344
345
346
Table 2, Continued. Comparative LC90 of four volatile pyrethroids, delivered as a vapor, to susceptible strains of four vector mosquito species a Exposure Reading b Pyrethroid Cx. quinquefasciatus An. quadrimaculatus
2 hours Transfluthrin 0.195 (0.124 – 0.306) 0.151 (0.107 – 0.215) Meperfluthrin 0.186 (0.126 – 0.274) 0.165 (0.104 – 0.261) Metofluthrin 3.666 (2.446 – 5.494) 0.211 (0.155 – 0.287) Prallethrin 2.397 (1.553 – 3.699) 3.301 (2.283 – 4.771) Flumethrin 156.367 (75.157 – 325.327) 3306.676 (1679.380 – 9307.141) 4 hours Transfluthrin 0.082 (0.055 – 0.123) 0.097 (0.068 – 0.138) Meperfluthrin 0.161 (0.109 – 0.237) 0.117 (0.074 – 0.184) Metofluthrin 2.280 (1.517 – 3.426) 0.209 (0.149 – 0.293) Prallethrin 1.439 (0.957 – 2.163) 2.610 (1.793 – 3.801) Flumethrin 134.516 (63.752 – 283.827) 2246.582 (942.308 – 5356.138) 24 hours Transfluthrin 0.111 (0.066 – 0.186) 0.065 (0.044 – 0.095) Meperfluthrin 0.121 (0.076 – 0.193) 0.066 (0.044 – 0.101) Metofluthrin 1.510 (0.981 – 2.325) 0.102 (0.077 – 0.137) Prallethrin 1.061 (0.665 – 1.693) 2.161 (1.432 – 3.260) Flumethrin 120.487 (56.241 – 258.121) 1076.406 (482.436 – 2401.667) 2 hours, Transfluthrin 0.136 (0.095 – 0.196) 0.191 (0.143 – 0.256) transferred Meperfluthrin 0.202 (0.144 – 0.283) 0.191 (0.123 – 0.296) Metofluthrin 11.858 (8.299 – 16.943) 0.146 (0.112 – 0.191) Prallethrin 1.811 (1.313 – 2.496) 4.836 (3.291 – 7.107) Flumethrin 263.637 (124.844 – 556.728) 3141.073 (1273.753 – 7745.880) a Values are LC50 with 95% fiduciary limits (lower FL, upper FL) shown in ppm (µg/cm3 or µg/ml). Based on serial dilutions of compounds applied to paper strips in a 473.18 ml air space. b Mosquitoes exposed without removal from original test container (2 hr, 4 hr, and 24 hr) and mortality recorded or exposed for 2 hr and transferred to clean containers with mortality recorded 24 hr after initial exposure.
FDACS Project P0010729 Final Report: September 2017
21
Figures 347
348
Figure 1. Metofluthrin extracts were fractionated using automated flash chromatography 349
(CombiFlash Rd 200i, Teledyne ISCO, Lincoln, NE). Fractions were delivered using pentane as 350
the a-polar solvent and ethyl ether as the polar solvent at a 10ml/min flow rate and a 5ml peak 351
runtime. 352
353
FDACS Project P0010729 Final Report: September 2017
22
354
Figure 2. Simultaneous mass spectrometry (Expressions CMS, Advion, Inc., Ithaca, NY) of 355
metofluthrin fractions during automated flash chromatography. 356
357
FDACS Project P0010729 Final Report: September 2017
23
358
Figure 3. Chemical solution being applied to Whatman No.1 filter paper, which was cut into 359
strips with dimensions of 5 mm x 40 mm, pleated every 5 mm in length. Applications were made 360
by using a 20-µl pipette fitted with a filter tip to administer 40 µl of solution in two passes. 361
Aliquots were kept in amber borosilicate vials to protect the chemical integrity. 362
363
364
FDACS Project P0010729 Final Report: September 2017
24
365
Figure 4. Clear polyethylene test containers with a volume of 473 ml. Snap-lids were modified 366
with a 20-mm opening to allow admission of 20 female, non-blood-fed, 5-7 day-old mosquitoes. 367
Left: Treated filter paper strips were contained within a 4 ml borosilicate vial to allow passage of 368
vapors while excluding direct contact. This method failed to allow consistent vapor dispersal. 369
Right: Cages were modified to a design where treated filter paper strips were contained within a 370
mesh bag suspended from the opening to allow passage of vapors while excluding direct contact. 371
Container openings were sealed during testing. This modification allowed consistent data 372
collection. 373
374
FDACS Project P0010729 Final Report: September 2017
25
Supplemental Figures 375
376
Supplemental Figure 1. Automated flash chromatography (CombiFlash Rd 200i, Teledyne 377
ISCO, Lincoln, NE) inputs/outputs for metofluthrin fraction separation. 378
FDACS Project P0010729 Final Report: September 2017
26
379
Supplemental Figure 2.1. Total ion chromatogram generated with atmospheric-pressure 380
chemical ionization. Fingerprinting of three out of four fraction cycles shown. 381
FDACS Project P0010729 Final Report: September 2017
27
382
Supplemental Figure 2.2. Total ion chromatogram generated with atmospheric-pressure 383
chemical ionization. Fingerprinting of the fourth of four fraction cycles shown. Followed by 384
tabulated output for all four chromatograms. 385
FDACS Project P0010729 Final Report: September 2017
28
386
Supplemental Figure 2.3. Positive and negative electrospray ionization responses, run in 387
tandem with mass spectrometry. 388